Innovent Biologics, Inc. (IVBIY)
OTCMKTS · Delayed Price · Currency is USD
51.09
0.00 (0.00%)
At close: Sep 25, 2025
Innovent Biologics Employees
Innovent Biologics had 5,659 employees as of December 31, 2024. The number of employees increased by 787 or 16.15% compared to the previous year.
Employees
5,659
Change (1Y)
787
Growth (1Y)
16.15%
Revenue / Employee
$257,593
Profits / Employee
$25,535
Market Cap
20.61B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 5,659 | 787 | 16.15% |
Dec 31, 2023 | 4,872 | -422 | -7.97% |
Dec 31, 2022 | 5,294 | -274 | -4.92% |
Dec 31, 2021 | 5,568 | 2,289 | 69.81% |
Dec 31, 2020 | 3,279 | 1,297 | 65.44% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Tian'an Technology Group | 8 |
Elite Pharmaceuticals | 68 |
Glass House Brands | 374 |
Northwest Biotherapeutics | 25 |
CytoDyn | 13 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
Jushi Holdings | 1,234 |